AI Model Uncovers Hidden Health Risks in Routine Sleep Studies
A newly developed AI model analyzes standard polysomnogram data to identify patient groups with varying long-term health risks.
A novel artificial intelligence (AI) model has been developed to utilize information collected during routine sleep studies to identify patients' long-term health risks.
The model, developed by a multidisciplinary research team, uncovered hidden sleep patterns linked to risks including heart disease, cognitive decline, and death. The findings suggest that routine medical tests may contain substantially more physiologic information than current clinical practice extracts from them.
Polysomnography collects rich data on each patient's brain, lungs, muscles, and heart, but clinicians have historically focused on a small subset of that information to grade sleep apnea severity.
| Measure | Description |
|---|---|
| AHI | Standard clinical measure used to assess sleep apnea severity |
| AI Model | Newly developed AI model that analyzes standard polysomnogram data to identify patient groups with varying long-term health risks |
The research revealed clinically meaningful patient subtypes with sharply different long-term health risks. Patients in the highest-risk group had twice the mortality risk over the next five years compared to those in the lowest-risk group, a distinction that was not captured by the standard clinical measure used to assess sleep apnea severity.
The model was developed by a collaborative team of sleep physicians, AI researchers, data scientists, and neuroscientists brought together through the Discovery Accelerator, a 10-year joint research partnership between Cleveland Clinic and IBM aimed at advancing the pace of discovery in life sciences through AI and quantum computing.
AI Model's Potential Impact on Sleep Medicine
The AI model could help researchers better understand how sleep impacts health outcomes. By looking beyond traditional measures, the approach uses AI to detect latent physiologic features invisible to the human eye and extract prognostic biomarkers that help stratify risk for cardiovascular and neurologic disease, and survival.
The model could also help researchers expand the value of routine sleep testing and reinforce the key role sleep plays in chronic disease. This discovery offers a more personalized approach to sleep medicine, potentially leading to earlier and more personalized care.
Future Directions for the Research
The next step is to validate these findings in diverse populations and expand collaborations among medical and technical experts, industry partners, and professional society stakeholders. This will help to further understand the potential of the AI model in identifying patient groups with varying long-term health risks.
The AI model has the potential to revolutionize the way sleep studies are analyzed and interpreted, leading to better patient outcomes and more personalized care.
